ANTI-BETA-CATENIN ANTIBODIES

The present disclosure relates to antibodies directed against betacatenin and formulations comprising the same. The disclosure further relates to the use of the beta-catenin antibodies and formulations in therapy, notably in the treatment of solid cancers. La présente invention concerne des anticorp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	STARKIE, Laura, LAWSON, Alastair David Griffiths, WRIGHT, Michael John
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to antibodies directed against betacatenin and formulations comprising the same. The disclosure further relates to the use of the beta-catenin antibodies and formulations in therapy, notably in the treatment of solid cancers. La présente invention concerne des anticorps dirigés contre la bêtacaténine et des formulations les comprenant. L'invention concerne en outre l'utilisation des anticorps anti-bêta-caténine et des formulations en thérapie, notamment dans le traitement de cancers solides.